+91 44 2496 8000 info@caplinpoint.net

News

Caplin Point up 20% on USFDA approval for Verapamil Hydrochloride injection

2Y1Y6M1M5D1D Shares of Caplin Point Laboratories were locked inthe 20 per cent upper circuit at Rs 245 on the BSE on Thursday after the company’s arm Caplin Steriles received final approval from the US drug regulator for Verapamil Hydrochloride injection. Verapamil Hydrochloride is a calcium channel blocker used in the treatment of cardiac conditions such…

Read More »

Caplin Point likely to end FY20 with 10% revenue from the US

Caplin Point Laboratories received the US Food and Drug Administration. (USFDA) nod for its generic medicine for blood pressure. The product is of strategic importance to the company because of some of the other drugs that it has in similar therapeutic segments. “This is a product that we filed for approval last year. We have…

Read More »